MyFinsight
Home
Blog
About
Contact
Download
Download image
Net decrease in cash
and cash...
-$11,466,632
Share-based compensation
expense
$409,220
Reduction in the carrying
amount of operating...
$31,418
Depreciation and
amortization expense
$4,687
Cash used in
operating activities
-$11,429,374
Cash used in
investing activities
-$37,258
Canceled cashflow
$445,325
Interest income
$520,139
Other income
(expense)
$143,088
Net loss
-$8,680,572
Prepaid expenses and
other current assets
$1,629,746
Accrued expenses and
other current...
-$1,466,525
Purchase of property and
equipment
$37,258
Canceled cashflow
$663,227
Accounts payable
-$67,158
Operating lease liability
-$30,698
Loss from operations
-$9,343,799
Operating
expenses-CTIM76
$2,284,033
Personnel-related costs
$2,203,587
Operating expenses-CT202
$1,904,761
Operating expenses-CT95
$1,389,773
Professional fees
$689,431
Other segment items
$462,994
Share-based compensation
$409,220
Back
Back
Cash Flow
source: myfinsight.com
Context Therapeutics Inc. (CNTX)
Context Therapeutics Inc. (CNTX)